JPRN-UMIN000037218招募中未知
Multi-institutional collaborative study on antigen-positive red blood cells (RBCs) transfusion for the patients who have corresponding irregular RBC antibodies - Multi-institutional collaborative study on antigen-positive red blood cells (RBCs) transfusion for the patients who have corresponding irregular RBC antibodies
Japan Erythrocyte Irregular Antibody Study Group0 个研究点目标入组 1,000 人开始时间: 2019年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases without any of the above mentioned criteria.
研究者
相似试验
招募中
Unknown
International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi Combined Vector-Based Vaccine against Ebola Virus Disease, 0.5 ml+0.5 ml/doseEbola Virus DiseasePACTR201702002053400Federal Research Centre for Epidemiology and Microbiology named after N.F. Gamaleya2,000
进行中（未招募）
不适用
Multicentre trial evaluating the immunogenicity of HPV vaccination in girls on immunosuppressive therapy. - PRIMAVERAInfection by HPV 6, 11, 16, 18EUCTR2011-006002-27-FRCHU de Bordeaux
已完成
3 期
A clinical study to assess the continued immunological existence of antibodies at 12, 24 and 36 months after receiving the primary dose.CTRI/2020/03/023712Biological ELimited233
已完成
不适用
Prospective multicentre trial of Antibody diagnostics in paediatric Coeliac DiseaseK90.0Coeliac diseaseDRKS00003854niversität LeipzigInstitut für Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik949
进行中（未招募）
不适用
A multicenter study to describe the immunogenic epitope(s) of factor VIII in previously treated patients with congenital hemophilia A who develop de novo factor VIII inhibitors while receiving factor VIII infusion therapy - N/AHaemophilia A is an X-linked recessive clotting disorder in which the clotting factor, factor VIII (FVIII), is deficient or inactive. Patients with low levels of FVIII have an increased tendency to bleed and is characterised by recurrent haemorrhages due to trauma, surgery or spontaneous haemorrhaging when the condition is severe.EUCTR2004-000219-24-DEWyeth Pharmaceuticals27